{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:52:51Z","timestamp":1794869571825,"version":"4.9.1"},"reference-count":100,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"9","license":[{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Iron-deficiency anemia and pre-anemic iron deficiency are the most frequent pathologies. The first line of treatment involves oral iron supplementation. The simplest, least expensive, and most commonly prescribed drug is ferrous sulfate, while other ferrous salts and ferric complexes with polysaccharides or succinylated milk proteins are also widely used. In recent years, novel iron formulations have been developed, such as the lipophilic iron donor ferric maltol, or nanoparticle encapsulated sucrosomial\u00ae iron. Oral iron supplementation is usually efficacious in correcting iron-deficiency anemia and replenishing iron stores but causes gastrointestinal side effects that reduce compliance. When oral iron supplementation is contraindicated, intravenous iron therapy can rapidly achieve therapeutic targets without gastrointestinal complications. Herein, we critically review literature on relative efficacy and tolerability of currently available oral iron supplements, and summarize recent data on optimal dosage and frequency.<\/jats:p>","DOI":"10.3324\/haematol.2024.284967","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T03:23:40Z","timestamp":1712805820000},"page":"2790-2801","source":"Crossref","is-referenced-by-count":79,"title":["Oral iron supplementation: new formulations, old questions"],"prefix":"10.3324","volume":"109","author":[{"given":"Kostas","family":"Pantopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,4,11]]},"reference":[{"key":"65301","doi-asserted-by":"crossref","unstructured":"Katsarou A, Pantopoulos K. Basics and principles of cellular and systemic iron homeostasis. Mol Aspects Med. 2020; 75:100866.","DOI":"10.1016\/j.mam.2020.100866"},{"key":"65302","doi-asserted-by":"crossref","unstructured":"Charlebois E, Pantopoulos K. Nutritional aspects of iron in health and disease. Nutrients. 2023; 15(11):2441.","DOI":"10.3390\/nu15112441"},{"key":"65303","doi-asserted-by":"crossref","unstructured":"Gulec S, Anderson GJ, Collins JF. Mechanistic and regulatory aspects of intestinal iron absorption. Am J Physiol Gastrointest Liver Physiol. 2014; 307(4):G397-G409.","DOI":"10.1152\/ajpgi.00348.2013"},{"key":"65304","doi-asserted-by":"crossref","unstructured":"Piskin E, Cianciosi D, Gulec S, Tomas M, Capanoglu E. Iron absorption: factors, limitations, and improvement methods. ACS Omega. 2022; 7(24):20441-20456.","DOI":"10.1021\/acsomega.2c01833"},{"key":"65305","doi-asserted-by":"crossref","unstructured":"Hooda J, Shah A, Zhang L. Heme, an essential nutrient from dietary proteins, critically impacts diverse physiological and pathological processes. Nutrients. 2014; 6(3):1080-1102.","DOI":"10.3390\/nu6031080"},{"key":"65306","doi-asserted-by":"crossref","unstructured":"Drakesmith H, Nemeth E, Ganz T. Ironing out ferroportin. Cell Metab. 2015; 22(5):777-787.","DOI":"10.1016\/j.cmet.2015.09.006"},{"key":"65307","doi-asserted-by":"crossref","unstructured":"Nemeth E, Ganz T. Hepcidin and iron in health and disease. Annu Rev Med. 2023; 74:261-277.","DOI":"10.1146\/annurev-med-043021-032816"},{"key":"65308","doi-asserted-by":"crossref","unstructured":"Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015; 372(19):1832-1843.","DOI":"10.1056\/NEJMra1401038"},{"key":"65309","doi-asserted-by":"crossref","unstructured":"Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet. 2021; 397(10270):233-248.","DOI":"10.1016\/S0140-6736(20)32594-0"},{"key":"65310","doi-asserted-by":"crossref","unstructured":"Drakesmith H, Pasricha SR, Cabantchik I. Vaccine efficacy and iron deficiency: an intertwined pair?. Lancet Haematol. 2021; 8(9):e666-e669.","DOI":"10.1016\/S2352-3026(21)00201-5"},{"key":"65311","unstructured":"GBD. Anemia Collaborators. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the Global Burden of Disease Study 2021. Lancet Haematol. 2021; 10(9):e713-e734."},{"key":"65312","doi-asserted-by":"crossref","unstructured":"da Silva Lopes K, Yamaji N, Rahman MO. Nutrition-specific interventions for preventing and controlling anaemia throughout the life cycle: an overview of systematic reviews. Cochrane Database Syst Rev. 2021; 9(9):CD013092.","DOI":"10.1002\/14651858.CD013092.pub2"},{"key":"65313","doi-asserted-by":"crossref","unstructured":"Nielsen OH, Soendergaard C, Vikner ME, Weiss G. Rational management of iron-deficiency anaemia in inflammatory bowel disease. Nutrients. 2018; 10(1):82.","DOI":"10.3390\/nu10010082"},{"key":"65314","doi-asserted-by":"crossref","unstructured":"Pergola PE, Fishbane S, Ganz T. Novel oral iron therapies for iron deficiency anemia in chronic kidney disease. Adv Chronic Kidney Dis. 2019; 26(4):272-291.","DOI":"10.1053\/j.ackd.2019.05.002"},{"key":"65315","doi-asserted-by":"crossref","unstructured":"Gowanlock Z, Lezhanska A, Conroy M. Iron deficiency following bariatric surgery: a retrospective cohort study. Blood Adv. 2020; 4(15):3639-3647.","DOI":"10.1182\/bloodadvances.2020001880"},{"key":"65316","doi-asserted-by":"crossref","unstructured":"Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019; 133(1):40-50.","DOI":"10.1182\/blood-2018-06-856500"},{"key":"65317","doi-asserted-by":"crossref","unstructured":"Girelli D, Ugolini S, Busti F, Marchi G, Castagna A. Modern iron replacement therapy: clinical and pathophysiological insights. Int J Hematol. 2018; 107(1):16-30.","DOI":"10.1007\/s12185-017-2373-3"},{"key":"65318","doi-asserted-by":"crossref","unstructured":"Lo JO, Benson AE, Martens KL. The role of oral iron in the treatment of adults with iron deficiency. Eur J Haematol. 2023; 110(2):123-130.","DOI":"10.1111\/ejh.13892"},{"key":"65319","doi-asserted-by":"crossref","unstructured":"Celis AI, Relman DA, Huang KC. The impact of iron and heme availability on the healthy human gut microbiome in vivo and in vitro. Cell Chem Biol. 2023; 30(1):110-126.","DOI":"10.1016\/j.chembiol.2022.12.001"},{"key":"65320","doi-asserted-by":"crossref","unstructured":"Kortman GA, Raffatellu M, Swinkels DW, Tjalsma H. Nutritional iron turned inside out: intestinal stress from a gut microbial perspective. FEMS Microbiol Rev. 2014; 38(6):1202-1234.","DOI":"10.1111\/1574-6976.12086"},{"key":"65321","doi-asserted-by":"crossref","unstructured":"Jaeggi T, Kortman GA, Moretti D. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut. 2015; 64(5):731-742.","DOI":"10.1136\/gutjnl-2014-307720"},{"key":"65322","doi-asserted-by":"crossref","unstructured":"Mayneris-Perxachs J, Cardellini M, Hoyles L. Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome. Microbiome. 2021; 9(1):104.","DOI":"10.1186\/s40168-021-01052-7"},{"key":"65323","doi-asserted-by":"crossref","unstructured":"Leung C, Rivera L, Furness JB, Angus PW. The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol. 2016; 13(7):412-425.","DOI":"10.1038\/nrgastro.2016.85"},{"key":"65324","doi-asserted-by":"crossref","unstructured":"Shah AA, Donovan K, Seeley C. Risk of infection associated with administration of intravenous iron: a systematic review and meta-analysis. JAMA Netw Open. 2021; 4(11):e2133935.","DOI":"10.1001\/jamanetworkopen.2021.33935"},{"key":"65325","doi-asserted-by":"crossref","unstructured":"Schaefer B, Tobiasch M, Wagner S. Hypophosphatemia after intravenous iron therapy: comprehensive review of clinical findings and recommendations for management. Bone. 2022; 154:116202.","DOI":"10.1016\/j.bone.2021.116202"},{"key":"65326","doi-asserted-by":"crossref","unstructured":"Rampton D, Folkersen J, Fishbane S. Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management. Haematologica. 2014; 99(11):1671-1676.","DOI":"10.3324\/haematol.2014.111492"},{"key":"65327","doi-asserted-by":"crossref","unstructured":"Santiago P. Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: a clinical overview. ScientificWorldJournal. 2012; 2012:846824.","DOI":"10.1100\/2012\/846824"},{"key":"65328","doi-asserted-by":"crossref","unstructured":"Feng Y, Wassie T, Wu Y, Wu X. Advances on novel iron saccharide-iron (III) complexes as nutritional supplements. Crit Rev Food Sci Nutr. 2023.","DOI":"10.1080\/10408398.2023.2222175"},{"key":"65329","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes GJ, Kolnagou A, Demetriou T, Neocleous M, Kontoghiorghe CN. New era in the treatment of iron deficiency anaemia using trimaltol iron and other lipophilic iron chelator complexes: historical perspectives of discovery and future applications. Int J Mol Sci. 2021; 22(11):5546.","DOI":"10.3390\/ijms22115546"},{"key":"65330","doi-asserted-by":"crossref","unstructured":"Gomez-Ramirez S, Brilli E, Tarantino G, Munoz M. Sucrosomial\u00ae iron: a new generation iron for improving oral supplementation. Pharmaceuticals (Basel). 2018; 11(4):97.","DOI":"10.3390\/ph11040097"},{"key":"65331","doi-asserted-by":"crossref","unstructured":"Pisani A, Riccio E, Sabbatini M. Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial. Nephrol Dial Transplant. 2015; 30(4):645-652.","DOI":"10.1093\/ndt\/gfu357"},{"key":"65332","doi-asserted-by":"crossref","unstructured":"Singh K, Sethi Chopra D, Singh D, Singh N. Nano-formulations in treatment of iron deficiency anaemia: an overview. Clin Nutr ESPEN. 2022; 52:12-19.","DOI":"10.1016\/j.clnesp.2022.08.032"},{"key":"65333","doi-asserted-by":"crossref","unstructured":"Cupone IE, Roselli G, Marra F. Orodispersible film based on maltodextrin: a convenient and suitable method for iron supplementation. Pharmaceutics. 2023; 15(6):1575.","DOI":"10.3390\/pharmaceutics15061575"},{"key":"65334","unstructured":"Huebers HA, Brittenham GM, Csiba E, Finch CA. Absorption of carbonyl iron. J Lab Clin Med. 1986; 108(5):473-478."},{"key":"65335","doi-asserted-by":"crossref","unstructured":"Seligman PA, Moore GM, Schleicher RB. Clinical studies of hip: an oral heme-iron product. Nutr Res. 2000; 20(9):1279-1286.","DOI":"10.1016\/S0271-5317(00)00215-3"},{"key":"65336","doi-asserted-by":"crossref","unstructured":"Conway RE, Geissler CA, Hider RC, Thompson RP, Powell JJ. Serum iron curves can be used to estimate dietary iron bioavailability in humans. J Nutr. 2006; 136(7):1910-1914.","DOI":"10.1093\/jn\/136.7.1910"},{"key":"65337","doi-asserted-by":"crossref","unstructured":"van Santen S, de Mast Q, Oosting JD. Hematologic parameters predicting a response to oral iron therapy in chronic inflammation. Haematologica. 2014; 99(9):e171-173.","DOI":"10.3324\/haematol.2014.106799"},{"key":"65338","doi-asserted-by":"crossref","unstructured":"Hoppe M, Hulthen L, Hallberg L. The validation of using serum iron increase to measure iron absorption in human subjects. Br J Nutr. 2004; 92(3):485-488.","DOI":"10.1079\/BJN20041207"},{"key":"65339","doi-asserted-by":"crossref","unstructured":"Geisser P, Burckhardt S. The pharmacokinetics and pharmacodynamics of iron preparations. Pharmaceutics. 2011; 3(1):12-33.","DOI":"10.3390\/pharmaceutics3010012"},{"key":"65340","doi-asserted-by":"crossref","unstructured":"Wienk KJ, Marx JJ, Beynen AC. The concept of iron bioavailability and its assessment. Eur J Nutr. 1999; 38(2):51-75.","DOI":"10.1007\/s003940050046"},{"key":"65341","doi-asserted-by":"crossref","unstructured":"Dignass AU, Gasche C, Bettenworth D. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015; 9(3):211-222.","DOI":"10.1093\/ecco-jcc\/jju009"},{"key":"65342","doi-asserted-by":"crossref","unstructured":"Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS ONE. 2015; 10(2):e0117383.","DOI":"10.1371\/journal.pone.0117383"},{"key":"65343","doi-asserted-by":"crossref","unstructured":"Ning S, Zeller MP. Management of iron deficiency. Hematology Am Soc Hematol Educ Program. 2019; 2019(1):315-322.","DOI":"10.1182\/hematology.2019000034"},{"key":"65344","doi-asserted-by":"crossref","unstructured":"Snook J, Bhala N, Beales ILP. British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut. 2021; 70(11):2030-2051.","DOI":"10.1136\/gutjnl-2021-325210"},{"key":"65345","unstructured":"Rudinskas L, Paton TW, Walker SE, Dotten DA, Cowan DH. Poor clinical response to enteric-coated iron preparations. CMAJ. 1989; 141(6):565-566."},{"key":"65346","doi-asserted-by":"crossref","unstructured":"Thankachan P, Bose B, Subramanian R, Koneri R, Kurpad AV. Fractional iron absorption from enteric-coated ferrous sulphate tablet. Indian J Med Res. 2020; 151(4):371-374.","DOI":"10.4103\/ijmr.IJMR_1464_18"},{"key":"65347","unstructured":"Delorme MA, Inwood MJ, Gwadry-Sridhar F. Enteric-coated iron tablets. CMAJ. 1990; 142(1):12-13."},{"key":"65348","doi-asserted-by":"crossref","unstructured":"Powers JM, Buchanan GR, Adix L. Effect of low-dose ferrous sulfate vs iron polysaccharide complex on hemoglobin concentration in young children with nutritional iron-deficiency anemia: a randomized clinical trial. JAMA. 2017; 317(22):2297-2304.","DOI":"10.1001\/jama.2017.6846"},{"key":"65349","doi-asserted-by":"crossref","unstructured":"Berber I, Diri H, Erkurt MA. Evaluation of ferric and ferrous iron therapies in women with iron deficiency anaemia. Adv Hematol. 2014; 2014:297057.","DOI":"10.1155\/2014\/297057"},{"key":"65350","doi-asserted-by":"crossref","unstructured":"Martinez Frances A, Leal Martinez-Bujanda J. Efficacy and tolerability of oral iron protein succinylate: a systematic review of three decades of research. Curr Med Res Opin. 2020; 36(4):613-623.","DOI":"10.1080\/03007995.2020.1716702"},{"key":"65351","doi-asserted-by":"crossref","unstructured":"Urso K, Leal Martinez-Bujanda J, Del Prado JM. Iron protein succinylate in the management of iron deficiency anemia: a comparative study with ferrous sulphate at low and high therapeutic doses. Nutrients. 2021; 13(3):968.","DOI":"10.3390\/nu13030968"},{"key":"65352","doi-asserted-by":"crossref","unstructured":"Fishbane S, Block GA, Loram L. Effects of ferric citrate in patients with nondialysis-dependent CKD and iron deficiency anemia. J Am Soc Nephrol. 2017; 28(6):1851-1858.","DOI":"10.1681\/ASN.2016101053"},{"key":"65353","doi-asserted-by":"crossref","unstructured":"Womack R, Berru F, Panwar B, Gutierrez OM. Effect of ferric citrate versus ferrous sulfate on iron and phosphate parameters in patients with iron deficiency and CKD: a randomized trial. Clin J Am Soc Nephrol. 2020; 15(9):1251-1258.","DOI":"10.2215\/CJN.15291219"},{"key":"65354","doi-asserted-by":"crossref","unstructured":"Schmidt C, Allen S, Kopyt N, Pergola P. Iron replacement therapy with oral ferric maltol: review of the evidence and expert opinion. J Clin Med. 2021; 10(19):4448.","DOI":"10.3390\/jcm10194448"},{"key":"65355","doi-asserted-by":"crossref","unstructured":"Howaldt S, Domenech E, Martinez N, Schmidt C, Bokemeyer B. Long-term effectiveness of oral ferric maltol vs intravenous ferric carboxymaltose for the treatment of iron-deficiency anemia in patients with inflammatory bowel disease: a randomized controlled noninferiority trial. Inflamm Bowel Dis. 2022; 28(3):373-384.","DOI":"10.1093\/ibd\/izab073"},{"key":"65356","doi-asserted-by":"crossref","unstructured":"Gomez-Ramirez S, Brilli E, Tarantino G, Girelli D, Munoz M. Sucrosomial\u00ae iron: an updated review of its clinical efficacy for the treatment of iron deficiency. Pharmaceuticals (Basel). 2023; 16(6):847.","DOI":"10.3390\/ph16060847"},{"key":"65357","doi-asserted-by":"crossref","unstructured":"Abbati G, Incerti F, Boarini C. Safety and efficacy of sucrosomial iron in inflammatory bowel disease patients with iron deficiency anemia. Intern Emerg Med. 2019; 14(3):423-431.","DOI":"10.1007\/s11739-018-1993-9"},{"key":"65358","doi-asserted-by":"crossref","unstructured":"de Alvarenga Antunes CV, de Alvarenga Nascimento CR, Campanha da Rocha Ribeiro T. Treatment of iron deficiency anemia with liposomal iron in inflammatory bowel disease: efficacy and impact on quality of life. Int J Clin Pharm. 2020; 42(3):895-902.","DOI":"10.1007\/s11096-020-01044-x"},{"key":"65359","doi-asserted-by":"crossref","unstructured":"Hussain U, Zia K, Iqbal R, Saeed M, Ashraf N. Efficacy of a novel food supplement (Ferfer\u00ae) containing microencapsulated iron in liposomal form in female iron deficiency anemia. Cureus. 2019; 11(5):e4603.","DOI":"10.7759\/cureus.4603"},{"key":"65360","doi-asserted-by":"crossref","unstructured":"Gordeuk VR, Brittenham GM, McLaren CE, Hughes MA, Keating LJ. Carbonyl iron therapy for iron deficiency anemia. Blood. 1986; 67(3):745-752.","DOI":"10.1182\/blood.V67.3.745.745"},{"key":"65361","doi-asserted-by":"crossref","unstructured":"Gordeuk VR, Brittenham GM, Bravo J, Hughes MA, Keating LJ. Prevention of iron deficiency with carbonyl iron in female blood donors. Transfusion. 1990; 30(3):239-245.","DOI":"10.1046\/j.1537-2995.1990.30390194345.x"},{"key":"65362","doi-asserted-by":"crossref","unstructured":"Gordeuk VR, Brittenham GM, Hughes M, Keating LJ, Opplt JJ. High-dose carbonyl iron for iron deficiency anemia: a randomized double-blind trial. Am J Clin Nutr. 1987; 46(6):1029-1034.","DOI":"10.1093\/ajcn\/46.6.1029"},{"key":"65363","doi-asserted-by":"crossref","unstructured":"Barraclough KA, Brown F, Hawley CM. A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial. Nephrol Dial Transplant. 2012; 27(11):4146-4153.","DOI":"10.1093\/ndt\/gfs372"},{"key":"65364","doi-asserted-by":"crossref","unstructured":"Nagaraju SP, Cohn A, Akbari A, Davis JL, Zimmerman DL. Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial. BMC Nephrol. 2013; 14:64.","DOI":"10.1186\/1471-2369-14-64"},{"key":"65365","doi-asserted-by":"crossref","unstructured":"Friling M, Garcia-Munoz AM, Perrinjaquet-Moccetti T. Tolerability of oral supplementation with microencapsulated ferric saccharate compared to ferrous sulphate in healthy premenopausal woman: a crossover, randomized, double-blind clinical trial. Int J Mol Sci. 2022; 23(20):12282.","DOI":"10.3390\/ijms232012282"},{"key":"65366","doi-asserted-by":"crossref","unstructured":"Chertow GM, Block GA, Neylan JF. Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease. PLoS One. 2017; 12(11):e0188712.","DOI":"10.1371\/journal.pone.0188712"},{"key":"65367","doi-asserted-by":"crossref","unstructured":"Gasche C, Ahmad T, Tulassay Z. Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program. Inflamm Bowel Dis. 2015; 21(3):579-588.","DOI":"10.1097\/MIB.0000000000000314"},{"key":"65368","doi-asserted-by":"crossref","unstructured":"Schmidt C, Ahmad T, Tulassay Z. Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a phase 3 study. Aliment Pharmacol Ther. 2016; 44(3):259-270.","DOI":"10.1111\/apt.13665"},{"key":"65369","doi-asserted-by":"crossref","unstructured":"Pergola PE, Kopyt NP. Oral ferric maltol for the treatment of iron-deficiency anemia in patients with CKD: a randomized trial and open-label extension. Am J Kidney Dis. 2021; 78(6):846-856.e1.","DOI":"10.1053\/j.ajkd.2021.03.020"},{"key":"65370","unstructured":"FDA. Drug Trials Snapshots: ACCRUFER. 2019. Publisher Full Text|"},{"key":"65371","doi-asserted-by":"crossref","unstructured":"Giordano G, Napolitano M, Di Battista V, Lucchesi A. Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant\/refractory to iron sulfate: a multicentric randomized study. Ann Hematol. 2021; 100(9):2173-2179.","DOI":"10.1007\/s00277-020-04361-3"},{"key":"65372","doi-asserted-by":"crossref","unstructured":"Antoine E, Mehedintu C, Mitran M, Diculescu D. Sucrosomial\u00ae iron effectiveness in recovering from mild and moderate iron-deficiency anemia in the postpartum period. BMC Pregnancy Childbirth. 2023; 23(1):360.","DOI":"10.1186\/s12884-023-05658-7"},{"key":"65373","doi-asserted-by":"crossref","unstructured":"Mwangi MN, Mzembe G, Moya E, Verhoef H. Iron deficiency anaemia in sub-Saharan Africa: a review of current evidence and primary care recommendations for high-risk groups. Lancet Haematol. 2021; 8(10):e732-e743.","DOI":"10.1016\/S2352-3026(21)00193-9"},{"key":"65374","doi-asserted-by":"crossref","unstructured":"Murdoch CC, Skaar EP. Nutritional immunity: the battle for nutrient metals at the host-pathogen interface. Nat Rev Microbiol. 2022; 20(11):657-670.","DOI":"10.1038\/s41579-022-00745-6"},{"key":"65375","doi-asserted-by":"crossref","unstructured":"Hutchinson C, Al-Ashgar W, Liu DY. Oral ferrous sulphate leads to a marked increase in pro-oxidant nontransferrin-bound iron. Eur J Clin Invest. 2004; 34(11):782-784.","DOI":"10.1111\/j.1365-2362.2004.01416.x"},{"key":"65376","doi-asserted-by":"crossref","unstructured":"Dresow B, Petersen D, Fischer R, Nielsen P. Non-transferrin-bound iron in plasma following administration of oral iron drugs. Biometals. 2008; 21(3):273-276.","DOI":"10.1007\/s10534-007-9116-5"},{"key":"65377","doi-asserted-by":"crossref","unstructured":"Schumann K, Solomons NW, Romero-Abal ME. Oral administration of ferrous sulfate, but not of iron polymaltose or sodium iron ethylenediaminetetraacetic acid (NaFeEDTA), results in a substantial increase of non-transferrin-bound iron in healthy iron-adequate men. Food Nutr Bull. 2012; 33(2):128-136.","DOI":"10.1177\/156482651203300206"},{"key":"65378","doi-asserted-by":"crossref","unstructured":"Brissot P, Ropert M, Le Lan C, Loreal O. Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta. 2012; 1820(3):403-410.","DOI":"10.1016\/j.bbagen.2011.07.014"},{"key":"65379","doi-asserted-by":"crossref","unstructured":"Tuomainen TP, Nyyss\u00f6nen K, Porkkala-Sarataho E. Oral supplementation with ferrous sulfate but not with non-ionic iron polymaltose complex increases the susceptibility of plasma lipoproteins to oxidation. Nutr Res. 1999; 19(8):1121-1132.","DOI":"10.1016\/S0271-5317(99)00073-1"},{"key":"65380","doi-asserted-by":"crossref","unstructured":"Toblli JE, Cao G, Angerosa M. Ferrous sulfate, but not iron polymaltose complex, aggravates local and systemic inflammation and oxidative stress in dextran sodium sulfate-induced colitis in rats. Drug Des Devel Ther. 2015; 9:2585-2597.","DOI":"10.2147\/DDDT.S81863"},{"key":"65381","doi-asserted-by":"crossref","unstructured":"Asperti M, Gryzik M, Brilli E. Sucrosomial\u00ae iron supplementation in mice: effects on blood parameters, hepcidin, and inflammation. Nutrients. 2018; 10(10):1349.","DOI":"10.3390\/nu10101349"},{"key":"65382","doi-asserted-by":"crossref","unstructured":"Kavakli K, Yilmaz D, Cetinkaya B. Safety profiles of Fe2+ and Fe3+ oral preparations in the treatment of iron deficiency anemia in children. Pediatr Hematol Oncol. 2004; 21(5):403-410.","DOI":"10.1080\/08880010490457114"},{"key":"65383","doi-asserted-by":"crossref","unstructured":"Lee T, Clavel T, Smirnov K. Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017; 66(5):863-871.","DOI":"10.1136\/gutjnl-2015-309940"},{"key":"65384","doi-asserted-by":"crossref","unstructured":"Constante M, Fragoso G, Lupien-Meilleur J, Calve A, Santos MM. Iron supplements modulate colon microbiota composition and potentiate the protective effects of probiotics in dextran sodium sulfate-induced colitis. Inflamm Bowel Dis. 2017; 23(5):753-766.","DOI":"10.1097\/MIB.0000000000001089"},{"key":"65385","doi-asserted-by":"crossref","unstructured":"Mahalhal A, Frau A, Burkitt MD. Oral ferric maltol does not adversely affect the intestinal microbiome of patients or mice, but ferrous sulphate does. Nutrients. 2021; 13(7):2269.","DOI":"10.3390\/nu13072269"},{"key":"65386","doi-asserted-by":"crossref","unstructured":"Zakrzewski M, Wilkins SJ, Helman SL. Supplementation with sucrosomial\u00ae iron leads to favourable changes in the intestinal microbiome when compared to ferrous sulfate in mice. Biometals. 2022; 35(1):27-38.","DOI":"10.1007\/s10534-021-00348-3"},{"key":"65387","doi-asserted-by":"crossref","unstructured":"Raza GS, Putaala H, Hibberd AA. Polydextrose changes the gut microbiome and attenuates fasting triglyceride and cholesterol levels in Western diet fed mice. Sci Rep. 2017; 7(1):5294.","DOI":"10.1038\/s41598-017-05259-3"},{"key":"65388","doi-asserted-by":"crossref","unstructured":"Schrier SL. So you know how to treat iron deficiency anemia. Blood. 2015; 126(17):1971.","DOI":"10.1182\/blood-2015-09-666511"},{"key":"65389","doi-asserted-by":"crossref","unstructured":"Moretti D, Goede JS, Zeder C. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015; 126(17):1981-1989.","DOI":"10.1182\/blood-2015-05-642223"},{"key":"65390","doi-asserted-by":"crossref","unstructured":"Stoffel NU, Cercamondi CI, Brittenham G. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol. 2017; 4(11):e524-e533.","DOI":"10.1016\/S2352-3026(17)30182-5"},{"key":"65391","doi-asserted-by":"crossref","unstructured":"Stoffel NU, Zeder C, Brittenham GM, Moretti D, Zimmermann MB. Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women. Haematologica. 2020; 105(5):1232-1239.","DOI":"10.3324\/haematol.2019.220830"},{"key":"65392","doi-asserted-by":"crossref","unstructured":"Kaundal R, Bhatia P, Jain A. Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia. Ann Hematol. 2020; 99(1):57-63.","DOI":"10.1007\/s00277-019-03871-z"},{"key":"65393","doi-asserted-by":"crossref","unstructured":"Duzen Oflas N, Demircioglu S, Yildirim Dogan N. Comparison of the effects of oral iron treatment every day and every other day in female patients with iron deficiency anaemia. Intern Med J. 2020; 50(7):854-858.","DOI":"10.1111\/imj.14766"},{"key":"65394","doi-asserted-by":"crossref","unstructured":"Kaynar LA, Gokcen S, Can F. Comparison of daily oral iron replacement therapy with every other day treatment in female reproductive age patients with iron-deficiency anemia. Ann Hematol. 2022; 101(7):1459-1464.","DOI":"10.1007\/s00277-022-04835-6"},{"key":"65395","doi-asserted-by":"crossref","unstructured":"Pasupathy E, Kandasamy R, Thomas K, Basheer A. Alternate day versus daily oral iron for treatment of iron deficiency anemia: a randomized controlled trial. Sci Rep. 2023; 13(1):1818.","DOI":"10.1038\/s41598-023-29034-9"},{"key":"65396","doi-asserted-by":"crossref","unstructured":"Fernandez-Gaxiola AC, De-Regil LM. Intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women. Cochrane Database Syst Rev. 2019; 1(1):CD009218.","DOI":"10.1002\/14651858.CD009218.pub3"},{"key":"65397","doi-asserted-by":"crossref","unstructured":"Wittker MC, Farrag K, Schr\u00f6der O, Aksan A, Stein J. Iron maltol versus ferrous sulphate in IBD-related anemia: does choice of iron compound make a difference to serum hepcidin levels?. Am J Gastroenterology. 2022; 117:S16-17.","DOI":"10.14309\/01.ajg.0000897756.98524.67"},{"key":"65398","doi-asserted-by":"crossref","unstructured":"Hanudel MR, Czaya B, Wong S. Enteral ferric citrate absorption is dependent on the iron transport protein ferroportin. Kidney Int. 2022; 101(4):711-719.","DOI":"10.1016\/j.kint.2021.10.036"},{"key":"65399","doi-asserted-by":"crossref","unstructured":"Asperti M, Brilli E, Denardo A. Iron distribution in different tissues of homozygous Mask (msk\/msk) mice and the effects of oral iron treatments. Am J Hematol. 2021; 96(10):1253-1263.","DOI":"10.1002\/ajh.26311"},{"key":"65400","doi-asserted-by":"crossref","unstructured":"Heeney MM, Finberg KE. Iron-refractory iron deficiency anemia (IRIDA). Hematol Oncol Clin North Am. 2014; 28(4):637-652.","DOI":"10.1016\/j.hoc.2014.04.009"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.284967\/76864","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.284967\/77419","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11548\/76864","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:06:13Z","timestamp":1794045973000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2024.284967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,11]]},"references-count":100,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.284967","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,11]]}}}